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Temporal lobe epilepsy (TLE) is the most common form of adult epilepsy that is amenable to surgical treatment. In the carefully
selected patient, excellent seizure outcome can be achieved with minimal or no side effects from surgery. This may result in
improved psychosocial functioning, achieving higher education, and maintaining or gaining employment. The objective of this
paper is to discuss the surgical selection process of a patient with TLE. We define what constitutes a patient that has medically
refractory TLE, describe the typical history and physical examination, and distinguish between mesial TLE and neocortical
TLE. We then review the role of routine (ambulatory/sleep-deprived electroencephalography (EEG), video EEG, magnetic
resonance imaging (MRI), neuropsychological testing, and Wada testing) and ancillary preoperative testing (positron emission
tomography, single-photon emission computed tomography (SPECT), subtraction ictal SPECT correlated to MRI (SISCOM),
magnetoencephalography, magnetic resonance spectroscopy, and functional MRI) in selecting surgical candidates. We describe
the surgical options for resective epilepsy surgery in TLE and its commonly associated risks while highlighting some of the
controversies. Lastly, we present teaching cases to illustrate the presurgical workup of patients with medically refractory TLE.
1. Introduction
1.1. History of Temporal Lobe Epilepsy Surgery. Cere-
bral localization and electroencephalography (EEG) have
together been two fundamental advances that have been
paramount in the diagnosis and management of epilepsy.
The clinical observations of Broca [1] and Jackson and
Colman [2], along with the landmark observations of
Fritsch and Hitzig [3], the electrical excitability of the
human brain, and discrete localization of brain functions,
began to be established. Through experiments of electrical
stimulation on narcotized dogs, Fritsch and Hitzig were
able to differentiate the motor from the nonmotor cortex
[3]. Drawn to these findings, Sir Horsley was likely the
first to attempt amelioration of epilepsy in a patient with
posttraumatic seizures via a craniotomy [4]. Not long after
this, in 1875, Caton was able to measure electrical activity
from the cat brain [5], and this was followed by EEG
recordings in humans by Berger in 1929 [6]. Thereafter,
Bailey and Gibbs proceeded to operate on individuals with
psychomotor epilepsy solely based on anterior temporal
spikes on EEG [7]. Penfield later observed that patients
failing neocortical resection could benefit from resection of
the mesial temporal lobe structures such as the amygdala
and the hippocampus. While many new developments have
occurred since, these represent the key contributions that
have remained as the fundamentals building blocks of the
modern-day practice of epilepsy surgery.
1.2. Background. With approximately 1% of the world
population affected by epilepsy, it is classified by the
International League Against Epilepsy (ILAE) as the most
common serious neurological disorder in the world [8]. The
annual incidence rate is between 40 and 70 per 1000 people
in developed countries [9]. Patients with epilepsy are at a
threefold higher risk of cognitive decline as compared to the
general population [10]. In addition, epilepsy is associated
with significant psychosocial harm including social isolation,
depression, and stigmatization [11]. Patients with epilepsy
are less likely to complete secondary and postsecondary
education translating into higher rates of unemployment
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[12]. In the United States, the direct average cost of epilepsy
is $10,000 a year for patients with medically uncontrolled
epilepsy and $2,000 a year for patients with medically
controlled epilepsy [13, 14]. However, the direct medical
costs comprise only 25% of the total economic impact of
epilepsy [15]. For the estimated 2.3 billion people with
epilepsy in the United States of America, the annual indirect
cost is $12.5 billion; costs are eightfold higher in patients with
medically intractable epilepsy [13, 16].
Medical intervention is the first step in the management
of epilepsy. However, this fails to achieve seizure freedom in
up to one-third of patients [17]. In a subset of patients who
are refractory to medical management, evaluation of surgical
candidacy is appropriate [18]. Temporal lobe epilepsy (TLE)
is particularly common and amenable to surgery resulting in
better seizure outcomes (50–70% seizure freedom at 5 years)
[19] as compared to extratemporal epilepsy [20]. In addition,
patients undergoing TLE surgery may benefit from improved
psychosocial functioning [21], achieving higher education,
maintaining or gaining employment [22], long-term seizure
freedom [23], in addition to significant monetary savings by
the society [9].
1.3. Objectives. The objective of this paper is to discuss
the surgical selection process of a patient with TLE. We
will outline the definition of a medically refractory patient
with TLE, distinguish between mesial TLE (mTLE) and
neocortical TLE (nTLE), review the role of routine and
ancillary preoperative testing, describe surgical techniques
and discuss common surgical risks. We lastly present several
case studies to review the rationale for surgery.
2. Selection of Patients for Temporal Lobe
Epilepsy Surgery
2.1. Medically-Refractory Temporal Lobe Epilepsy. A recent
consensus paper definedmedically refractory epilepsy as hav-
ing seizures despite being treated with 2 consecutive first-line
antiepileptic medications (AEDs) over 2 years [24]. Complex
partial seizures (CPSs), most commonly generated in the
temporal lobe, are least likely to respond tomedications [25].
Patients with CPSs, along with radiographic abnormalities
in the temporal lobe or mesial temporal sclerosis (MTS),
are most likely to fail medical management and are amongst
the best surgical candidates [26]; hence why TLE could be
considered a surgically-remediable form of epilepsy from the
onset [27]. A small proportion of patients with mTLE may
ultimately become seizure-free with more drug trials [20].
Furthermore, another subgroup of patients may achieve
seizure freedom without treatment. This is referred to as
benign mTLE in which the etiology may have an underlying
genetic component [28]. There is scarce data regarding the
predictors of this condition [28].
2.2. Differentiating between Mesial and Neocortical Temporal
Lobe Epilepsy. From an electrical and clinical perspective,
there are two subtypes of TLE: mTLE and nTLE. This
distinction is made (although there is indeed overlap) as
it has important implications with respect to electrophys-
iology, neuropsychological profile, underlying pathological
substrate, and response to surgery [29]. The electroclinical
and diagnostic differences are presented in Table 1.
The most common pathological substrate for TLE is
MTS. This is characterized by segmental loss of pyra-
midal cells, dispersion of granule cells, and a resultant
reactive gliosis. Other pathological entities resulting in
TLE include tumors (either malignant or benign, e.g.,
ganglioglioma, dysembryoplastic neuroepithelial tumour,
oligodendroglioma, low- or high-grade glioma, and menin-
giomas), infections (e.g., herpes, tuberculosis, and cysticer-
cosis), vascular malformations (arteriovenous malforma-
tions, cavernous hemangioma, and meningioangiomatosis),
migrational disorders (cortical dysplasia and hamartoma),
and trauma (encephalomalacia and gliosis). The differential
diagnosis of nTLE is similar to mTLE with the exception of
MTS.
2.2.1. Dual Pathology. Approximately 15% of patients with
partial epilepsy that have an extratemporal lesion have
associated MTS; these cases are referred to as involving dual
pathology [30]. The amount of hippocampal cell loss is
correlated to the specific type of extra-temporal pathology
with vascular lesions, gliomas, and hamartomas resulting in
the least amount of cell loss while heterotopias are associated
with the greatest amount of cell loss [30, 31]. While it is
not clear whether it is the hippocampus alone, the extra-
temporal lesion, or both that serve as the true epileptogenic
lesion, it is evident that resection of both lesions generally
yields the highest likelihood of attaining seizure freedom,
provided that preoperative testing demonstrates concordant
localization [32].
2.3. Routine Diagnostic Workup
2.3.1. Goal of Presurgical Patient Evaluation. The main goal
of surgical management of epilepsy is the removal of the
epileptogenic zone: the region which, if resected completely,
would result in seizure freedom [33]. Hence, the preoperative
workup seeks to identify this region and determine the safety
of its resection. As part of the evaluation, the ictal onset
zone, the symptomatogenic zone, the irritative zone, and
the functional deficit zone may also be identified. The ictal
onset zone is the region from which seizures arise. The
symptomatogenic zone reproduces the clinical semiology of
the ictal episodes upon stimulation. The irritative zone is the
region in which interictal discharges can be detected; this
depends highly on the method used for measurement, the
level of patient awareness, and the amount of medication
they are on. The functional deficit zone is correlated to
neurological deficits during the interictal period. In an
ideal scenario, substantial overlap is observed between the
aforementioned zones, and there is congruence with the
epileptogenic lesion identified on imaging. In such cases,
there is a high likelihood that the patient will attain seizure
freedom postoperatively [34–36].
These concepts are simplifications, and they may not be
accepted amongst all epileptologists. An alternative method
of conceptualizing seizure onset and propagation is the
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Table 1: Electroclinical and diagnostic differences between mTLE and nTLE.
mTLE nTLE
Clinical aspects
Auras (simple partial seizures)
(i) Not present in approximately half of TLE patients
(ii) Visceral sensation/fear (or both)
(iii) De´ja` vu
(iv) Illusions/hallucinations
Complex partial seizures
(i) Autonomic changes
(ii) Arrest of behavior/motionless stare
(iii) Oroalimentary automatism
(iv) Contralateral dystonic posturing
(v) Nose rubbing
(vi) Dysphasia (if dominant hemisphere involved)
Same as mTLE
Preoperative testing
MRI
(i) MTS
(ii) Other structural pathologies
(iii) Dual pathology
(iv) No lesion (“MRI normal”)
TLE
Same as mTLE
Neuropsychological testing
(i) Lateralized memory impairment
Neuropsychological testing
(i) More likely to have naming
problems
Wada test
(i) Less likely to have lateralized
memory dysfunction on side of
seizure onset, compared with mTLE
Scalp EEG
(i) “Classic” anterior temporal inter-ictal spikes
Scalp EEG
(i) No unique pattern
(ii) Absence/multiple types of
inter-ictal spikes
Intracranial recordings Seizures originate from mesial structures
Variable with widespread
electrophysiological changes
theory of cortical and subcortical neuronal networks (NNs);
these are bilateral brain regions that are interconnected
functionally and anatomically [37]. Individual components
within the network have the ability to influence each other
and the particular clinical semiology, and electrographi-
cal seizure manifestation is dependent on the particular
NN involved. A well-defined NN is the medial temporal-
limbic network consisting of the hippocampus, amygdala,
neocortex of the lateral temporal lobe, entorhinal cortex,
medial thalamus, and the inferior region of the frontal
lobes. The identification of NNs typically involves the use
of ictal EEG in addition to PET and fMRI [38]. Based on
this premise, the identification of any perturbation within
the network can be used to predict a seizure before it is
clinically and electrographically manifested. Further, the use
of NNs can be used to tailor treatment strategies to the
particular network involved. For example, the resection of
a component within the network but distant from eloquent
cortex could theoretically help diminish seizure frequency
without significant morbidity to the patient [37]. The
primary focus of this review paper will be based on the
epileptogenic and related zones and the various diagnostic
modalities that can be used to identify them.
2.3.2. History and Physical Examination. The presurgical
workup requires a detailed history and physical exam.
Specific components of the history include a detailed account
of seizure semiology, past medical history, family history, and
attempted AED. Having a family member or friend who has
witnessed the episodes can provide useful information, as
the individual may not have any recollection of the events.
A complete neurological examination can have localization
value and, together with the history, can help identify the
functional deficit zone.
2.3.3. Ambulatory and Sleep Deprived Electroencephalogram.
Scalp EEG is an essential component of the initial patient
evaluation. This test is often performed on an outpatient
basis both for convenience and its noninvasive nature. For
outpatient analysis, a 30-minute awake/sleep-deprived analy-
sis may suffice if there is a typical clinical history and obvious
imaging findings, especially if ictal recording with video-EEG
telemetry in a monitoring unit is not possible [39]. However,
there are situations where this may not be sufficient, for
example, bilateral TLE with unilateral hippocampal sclerosis
(HS). Repeated EEG, especially if performed within 48
hours of a seizure, increases the sensitivity of detecting an
abnormality [40]. Sleep deprivation or cessation of AEDs
can also be used to induce seizures [41]. Most patients with
mTLE have unilateral anterior temporal inter-ictal spikes
on surface EEG. However, some patients with unilateral
mTLE may have bilateral independent spikes in the anterior
4 Epilepsy Research and Treatment
temporal lobes [20]. Some authors report that unilateral
temporal rhythmic theta activity less than 30 seconds after
electrical seizure onset is associated with ipsilateral mTLE
[42]. Scalp EEG analysis is an invariable test performed at
all comprehensive epilepsy centers. By detecting ictal and
inter-ictal epileptic discharges, it enables the approximate
delineation of the ictal onset and the irritative zones. At
most centers, however, surgery is only undertaken after
documentation of seizure onsets after long-term video
monitoring in an epilepsy monitoring unit (EMU) [43].
2.3.4. Video Electroencephalography. Admission to the EMU
for continuous scalp EEG and video monitoring is the final
common pathway and is usually considered a necessary step
in determining surgical candidacy. This provides localizing
value for both inter-ictal and ictal onset zones, allowing
for correlation of the clinical manifestation of the epileptic
event to ictal and inter-ictal EEG activity. The patient may
be subjected to provocative measures such as medication
reduction, sleep deprivation, hyperventilation, or photic
stimulation to increase the likelihood of capturing epilepti-
form activity [44]. In certain situations, invasive electrodes
may be necessary to provide better localization (see below).
2.3.5. Magnetic Resonance Imaging. Magnetic resonance
imaging (MRI) scanning has significantly aided the diagnosis
and management of epilepsy, and it has been established
as the key imaging modality of choice [45]. If neocortical
epilepsy is suspected, imaging protocol should include a
whole head thin-sectioned high-resolution 3D T1- and T2-
weighted images as well as a gradient echo T2 sequence
to investigate the presence of blood products. Gadolinium
administration is not necessary unless a mass lesion or
tumour is found. If mTLE is suspected, high-resolution
coronal T1, T2 and fluid-attenuated inversion recovery
(FLAIR) sequences through the hippocampus should be
obtained, preferably with a 3 Tesla scanner [46]. HS is iden-
tified through volume acquisition T1-weighted MR images
along with FLAIR sequences [45]. T2-weighted imaging
can identify increased T2 signal in the mesial temporal
lobe and atrophy of the hippocampus, both key features
of MTS [47, 48]. The presence of hippocampal atrophy on
preoperative MRI has been associated with good seizure
outcomes following temporal lobectomy (TLY) [20]. Thus,
MR imaging allows for the identification of the postulated
epileptogenic lesion, which can be used in parallel with other
diagnostic modalities to help localize the epileptogenic zone.
2.3.6. Neuropsychological Assessment. A comprehensive neu-
ropsychological evaluation can identify preoperative func-
tional deficits and predict postoperative neuropsychological
outcomes [49]. The most important cognitive domains to
be tested in TLE are memory and language [49]. Patients
with dominant lobe TLE typically display verbal memory
deficits, whereas those with nondominant TLE display
visuospatial memory deficits. Word-finding difficulties (a
neocortical function) are also common in patients with
language dominant TLE [50, 51].
Memory decline is the most common deficit following
TLE surgery. The relationship between verbal memory
decline following left sided surgery is more robust compared
to the relationship between visuospatial memory decline
following right-sided surgery [52–54]. Patients with average
or above average memory and language function are at
a higher risk for developing postoperative deficits [55,
56]; therefore, a comprehensive preoperative discussion is
necessary with such patients before offering surgical man-
agement. Conversely those individuals with histologically
proven MTS are least likely to show significant memory
decline postoperatively [57].
2.3.7. Wada Test. The Wada test has been traditionally
used to assess language and memory function of the two
cerebral hemispheres independently [58, 59]. The agent most
commonly used is amobarbital, but other agents such as
methohexital, propofol, and etomidate have also been used
[60, 61]. Recently amobarbital has become unavailable in
some countries. Cerebral angiography is used to assess the
vasculature and extent of cross-over flow to contralateral
arteries. Baseline memory function is typically assessed a day
before the actual test. Prior to injection of the intra-arterial
anesthetic agent, the patient is asked to elevate both arms
(to monitor the development of contralateral hemiplegia
as a surrogate for adequate anesthesia) and count out
loud. Language and memory are assessed while hemiplegia
persists. Efforts are made to evaluate the side harboring
the postulated epileptogenic zone first; the contralateral
hemisphere is usually tested 30minutes after the initial
injection although some centers choose a one-day delay.
Global aphasia develops upon the injection of the
dominant hemisphere. The duration of speech arrest can
also be used to identify the language-dominant hemisphere.
However, some suggest that if the difference in time to
development of speech arrest is less than 30 seconds
among the two hemispheres, the patient may have bilateral
cortical language representation. Other parameters such
as dysarthria and paraphasias may also be used to assess
language dominance. Recent studies suggest that language
lateralization is a continuum between both hemispheres, and
that language unilateralitymay be secondary to a lesion in the
contralateral hemisphere [62].
For memory evaluation, the patient is required to
correctly identify items shown during hemiparesis. An
overall passing score is assigned based on the ability of the
contralateral side in supporting memory upon injection of
the side ipsilateral to the epileptogenic focus. Scores ranging
from 50 to 67% have been deemed as a pass [63, 64]. While
there is no gold standard to compare the Wada test results
to, a passing score has been associated with a decreased
likelihood of postoperative amnesia [2]. Based on the same
premise, the Wada test can also be used to lateralize the
epileptogenic zone in TLE patients. Injection of the side
contralateral to the seizure focus would be expected to result
in a greater loss of memory function with the correlation
being stronger if profound amnesia is observed.
Despite the high accuracy of the Wada test in lateralizing
language and memory function, this test is associated with
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false negatives and false positives [65]. These have important
clinical implications. For example, some patients may be
deemed unsuitable surgical candidates when in fact they
would benefit from surgery. Also, less hippocampal resection
may be performed resulting in poorer seizure control
postoperatively [57].
The Wada test results can be affected by a variety of
factors such as drug dose, unblinding of test assessors, and
patient cooperation. Furthermore, theWada test is associated
with risks such as seizures, contrast allergy, catheter site
hematoma, dissection, stroke, and infection [66, 67]. The risk
of arterial dissection or stroke is estimated at 1% [68]. As a
result many centers selectively use the WADA test [68] for
certain clinical situations only, for example, a nonconcordant
neuropsychological profile (memory deficit contralateral to
the site of MTS) or patients who have bilateral memory
deficits. Others restrict its use to left-handed individuals or
those with ictal/postictal aphasia [69].
2.3.8. Invasive EEG Monitoring. Scalp EEGs are unable to
lateralize the epileptogenic side in up to one-third of patients
with TLE [70]. Even in cases where noninvasive tests are
lateralizing, up to 10% could be falsely localizing [71]. In
addition, synchronous activity across a cortical region of
at least 6 cm2 is necessary for detection of an abnormality
on scalp EEG [72]. Thus the indications for invasive
recordings that stem from the limitations of scalp recordings
include discordance amongst the various preoperative tests,
seemingly multifocal epilepsy which includes bitemporal
epilepsy, MRI-negative TLE that requires discrimination
between nTLE and mTLE and as well to determine the
extent of resection [73], situations where scalp recorded
fields exceed the spatial involvement that would be expected
in either lesional epilepsy or MTS, and proximity of neo-
cortical lesions to eloquence are amongst the most common
indication, but this by no means represents an exhaustive
list. In patients with scalp EEG suggestive of bitemporal
abnormalities, depth electrodes can be placed bilaterally
within the mesial temporal lobe structures to lateralize the
seizure focus. Certain TLE patients can present with dual
pathology wherein it is unclear whether the hippocampus
alone, the extra-hippocampal pathology, or a combination of
the two is the epileptogenic lesion [31]. If the analysis shows
concordant localization, then removal of both lesions results
in the highest likelihood of seizure freedom postoperatively
[32]. In certain situations, such as tuberous sclerosis, cortical
dysplasia, or head trauma, invasive EEG may be necessary
as the epileptogenic zone may extend beyond the visible
lesion [74, 75]. Seizures that do not present with classic
mesial temporal IEDs attributed to mTLE are likely to be of
neocortical origin. If there is concern regarding proximity to
eloquent cortex, subdural or depth electrodes can be used
to better map the epileptogenic and functional areas, thus
identifying a safe resection margin for the patient [76].
With invasive recordings, the characteristic ictal EEG
pattern of mTLE includes periodic spiking activity from the
hippocampus followed by episodes of high-voltage rhythms,
which can last up to one minute. Subsequently, a regular
5–9Hz rhythm is commonly observed [77]. In nTLE, ictal
rhythms show high variability but a low voltage, high
frequency discharge is commonly observed. Sharp waves
of low frequency are also highly specific for seizures of a
neocortical origin [69]. Patients with focal cortical dysplasia
may demonstrate well-localized fast rhythms or repetitive
fast spikes.
Upon the completion of scalp/invasive EEG video moni-
toring, some patients will have epilepsy that not amenable to
surgery. This can be attributed to a myriad of causes includ-
ing psychogenic nonepileptic seizures (PNESs), multifocal
epilepsy, patients having a generalized seizure disorder, or
the inability to accurately localize the ictal focus. However,
almost half of the patients that flow through an adult EMU
will have a distinctively identifiable symptomatogenic zone
or will warrant intracranial recordings to determine surgical
candidacy.
Furthermore, as deep seated or even certain superficial
epileptiform activities may bemissed by scalp EEG due to the
filtering effect of the skull on higher frequency signals [78],
intracranial recordings and in particular depth electrodes are
of utility in recording from these electrographically occult
lesions. While “ripples” (100–200Hz) are associated with
normal hippocampal electrical activity, fast ripples (150–
500Hz frequency) have a high likelihood of being associated
with the ictal onset zone in the epileptogenic hippocampus
and parahippocampal regions in patients with MTS [79–81].
While “fast ripple” detection holds great potential for the
identification of the epileptogenic zone, its testing is invasive
and is therefore restricted to seizure patterns originating
from the hippocampus and hence less applicable to nTLE
[81].
Although in extratemporal epilepsy detection of residual
interictal epileptiform activity at themargins of resection can
assist in deciding whether further resection is necessary, this
approach appears to have little utility in the temporal lobe
[27]. Disadvantages of intraoperative electrode recordings
include the additional cost of equipment and extra operating
room time, the need for an experienced neurophysiologist,
and the rare occurrence of ictal recordings. Furthermore,
with improvements in preoperative invasive monitoring, the
need for intra-operative monitoring has decreased. Even
though the use of invasive recording in general has dimin-
ished over time, it is nonetheless a valuable tool in select
cases. Regardless, before embarking on invasive monitoring,
the clinical question must be clear and the answer derived
from the test should aid in the surgical evaluation of the
patient.
2.4. Ancillary Testing. In situations where the standard
presurgical assessment does not provide definitive seizure
lateralization and/or localization (e.g., when the seizure
focus appears to be bilateral, temporal, and extratemporal,
mTLE with a larger field of activity than would otherwise
be expected from standard mTLE), or there is discrepancy
between the presurgical tests, the following ancillary investi-
gations can be performed.
2.4.1. Positron Emission Tomography. Positron emission
tomography (PET) is an imaging modality that uses radioac-
tive isotopes linked to metabolically active molecules (such
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as glucose) to analyze functionality in various regions of
the body depending on metabolic activity. The nuclei of
these tracers emit positrons which generate photons upon
collision with electrons in the surrounding environment. The
concentration of radioactive glucose, and hence amount of
photon emission, within a region depends on the relative
metabolic activity. Hypometabolism is not correlated with
the amount of cell loss or hippocampal atrophy. In the
investigation of TLE, this test seeks to identify the region of
interictal hypometabolism which is slightly larger than the
ictal onset zone. Occasionally in TLE, hypometabolism can
be detected in regions other than the temporal lobe. This may
reflect the extratemporal connections of the seizure focus
[82].
Although obtaining a truly ictal PET study is rare, it can
be valuable in identifying the seizure focus, by demonstrating
a marked area of hypermetabolism [45, 83]. Accordingly,
EEG recording during PET acquisition is important to
ensure hypometabolism detected in one hemisphere is not
secondary to an active seizure on the contralateral side
resulting in hypermetabolism [84].
Fluorodeoxyglucose (FDG) is the most commonly used
isotope in PET. The inter-ictal FDG-PET has a high speci-
ficity for mTLE (MTS is associated with hypometabolism
localized to the hippocampus, amygdala, entorhinal cortex,
and temporal pole) [20, 85]. In addition, hypometabolic
regions identified by FDG-PET correlate well with predicted
lateralization when compared to depth electrodes [86].
The sensitivity of the test is increased when the metabolic
activity of both temporal lobes is sampled to quantify
hypometabolism on one side in relation to the other.
PET is generally utilized in the evaluation of symp-
tomatic (formerly referred to as cryptogenic) cases and
for identifying seizure-spread patterns, thus guiding the
placement of intracranial electrodes. If PET and MRI are
concordant, there is prognostic utility as better seizure
outcomes are predicted following surgery. However, PET
does not usually provide any additional information if MTS
is demonstrated on MRI [87, 88]. Therefore, it is not
commonly used at all centers for presurgical evaluation.
2.4.2. Single Photon Emission Computed Tomography. Cere-
bral blood flow is increased within regions of the brain
undergoing epileptic seizures to match the increased
metabolic demand. Single photon emission computed
tomography (SPECT) measures local cerebral perfusion
using either technetium-99m hexamethyl propelene amine
oxime or technetium-99m bicisate. These can be maximally
extracted into the neurons within seconds of injection and
remain within the cell for several hours [89]. Therefore,
injection of radiotracers immediately following a seizure
can help identify the ictal onset zone. The sensitivity of
this test is increased further if inter-ictal SPECT studies
are used for comparison to determine the relative change
in cerebral perfusion during seizures. SPECT can be used
as an important adjunct for localization of seizure onset,
particularly in MRI-normal cases or when EEG is non-
localizing [90]. While the spatial and temporal resolutions
of SPECT are not as high as PET, it is less costly and more
widely available.
When independent seizure foci reside in the temporal
lobes bilaterally, ictal SPECT studies must be interpreted
with caution. Furthermore, SPECT may provide falsely
lateralizing information if the epileptiform activity has
terminated in the temporal lobe of origin but is ongoing in
the contralateral temporal lobe. In certain cases of nTLE, the
regional cerebral blood flow cannot be accurately identified
by inter-ictal SPECT; therefore, SPECT is overall less sensitive
for nTLE. Currently, SPECT imaging can only be used
to provide information that is complementary to EEG.
However, modifications to the SPECT analysis (as discussed
below) can increase its utility in identifying the ictal zone.
2.4.3. Subtraction Ictal SPECT Correlated to MRI. With
a higher accuracy than SPECT, subtraction ictal SPECT
correlated to MRI (SISCOM) is another imaging modality
that can be used to localize the epileptogenic zone, especially
for those with nonlesional MRI or extensive focal cortical
dysplasia [91]. In SISCOM, normalized coregistered inter-
ictal SPECT images are subtracted from ictal images, and the
resultant difference in cerebral blood flow (only those with
intensities greater than 2 standard deviations above zero)
is matched to high-resolution corresponding MR images
to identify the epileptogenic zone [89]. Spiral CT images
of implanted subdural electrodes can also be coregistered
with SISCOM images to correlate changes in cerebral
perfusion with the ictal onset zone [92]. SISCOM can also
be used to guide intracranial EEG electrode placement [92].
Concordance of SISCOM with other preoperative studies
identifying the epileptogenic focus may have prognostic
value in postoperative seizure outcomes [91].
To improve the diagnostic yield of SISCOM, injection
of radiotracers should be performed within 45 seconds of
seizure onset and ideally the seizure lasting greater than 5–
10 seconds [93]. Furthermore, for accurate correlation to
the epileptogenic zone, continuous EEG (cEEG) recordings
are required. In addition, the cost of the radioisotopes is
relatively high as well. Therefore, despite SISCOM’s clinical
utility, its use is limited to certain comprehensive epilepsy
centers.
2.4.4. Magnetoencephalography. The neurophysiologic pro-
cess that generates themagnetoencephalogram (MEG) signal
is identical as to what produces the EEG [94]. The fluctuation
of the dendritic membrane potential is observed as a current
dipole perpendicular to the cortical surface [95]. A certain
volume of excitable cortex is required to generate a “brain
wave” which is detected by MEG or EEG. MEG spike
localization does not necessarily identify the epileptogenic
zone or seizure onset zone. However, it does detect inter-
ictal epileptiform discharges (IEDs) generated within the
neocortex [96, 97].
The current indication for MEG in TLE is unknown, and
its potential advantage must be weighed against the high
cost and limited availability. In a retrospective study, it was
found that MEG utilized in the presurgical evaluation did
not provide any additional information in over half of the
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patients [98]. Its utility in mTLE is suspect given its inability
to detect deep sources and in particular hippocampally
generated IEDs [99, 100]. Its benefit is likely larger in
neocortical epilepsy or in those with equivocal findings
following other testing modalities [98, 101]. Its greatest
utility is perhaps in non-lesional TLE cases where a strong
correlation has been established betweenMEG spike patterns
and the seizure onset zone [102]. MEG may at the very
least provide more support for the recommended treatment
strategy, whether for or against surgery. The main advantage
of MEG over scalp EEG is its improved accuracy in spike
source localization. Although it must be borne in mind
that MEG provides complimentary information to EEG, the
sources that generate MEG signals are thought to arise from
the sulci, whereas those generating the EEG signals arise
from the crowns of the gyri [100]. As well, it can also be
superimposed on other functional imaging modalities and
guide surgical resections as part of the neuronavigational
system [103, 104].
2.4.5. Magnetic Resonance Spectroscopy. N-Acetylaspartate
(NAA) is primarily found in neurons, and its decrease is
often indicative of neuronal loss or dysfunction. In contrast,
creatinine (Cr) and choline (Cho) are present at higher
concentrations within glial cells. By studying the levels of
NAA, Cr, and Cho, 1H magnetic resonance spectroscopy
(MRS) can also be helpful in localizing the epileptogenic
zone. A decrease in the ratio of NAA to Cr + Cho has
been suggested to be correlated with HS with correct
seizure lateralization in greater than 90% of cases [105]. A
proportion of patients may demonstrate bilateral metabolic
abnormalities with 1H MRS; this may correlate with a higher
likelihood of surgical failure [73]. 1H MRS can aid in the
placement of intracranial grid and strip electrodes as well
[73]. However, due to its technical challenges and lack of
widespread availability, this tool has yet to be established in
the presurgical evaluation of epilepsy although it may have
an expanded utility in the future [106].
2.4.6. Functional MRI. Functional MRI (fMRI) studies neu-
ral activity by measurement of alteration in the MRI signal
due to changes in oxygenation levels (an increase in T2
signal is observed during epileptiform activity) [107]. The
main indications for this imaging modality are for the
identification of eloquent cortical regions such as motor
and language areas. In addition, when coupled with EEG
analysis, it can also be used to help identify the irritative
zone and potentially the ictal onset zone [108]. Significant
improvements in EEG-fMRI analysis (e.g., MRI-compatible
EEG electrodes, higher strength magnets, and offline signal
processing using mathematical tools) [109] have increased
the application of this imaging modality in the evaluation
of patients with epilepsy. Amongst its many advantages,
fMRI has a spatial resolution of a few millimeters and it
is a noninvasive alternative for the Wada test for language
lateralization and localization of cortical speech regions
[110]. Increased signal activation on fMRI during memory
and language tasks on the side ipsilateral to the ictal focus
has been suggested to be associated with greater deficits
post resection [111, 112]. This correlation may be an even
stronger predictor than neuropsychological testing [112].
While fMRI is a sensitive tool for the evaluation of the
irritative zone, its sensitivity to patient motion, including
changes in patients’ cardiac and respiratory parameters,
makes it difficult to fully evaluate the ictal onset zone.
However, the development of specific algorithms to adjust
for these artifacts may allow fMRI to become a standard
component of the presurgical evaluation.
3. Surgical Strategy
3.1. Extent of Lateral Resection. The extent of lateral resection
is variable and commonly dependent on strategies to avoid
postoperative language deficits and whether or not the
patient has mTLE or nTLE.
3.1.1. mTLE. One approach to mTLE is to resect a pre-
determined amount of neocortex according to language
dominance: 4.5 cm and 5 cm along the Sylvian fissure in
the dominant and nondominant sides, respectively [113,
114]. Resections beyond this length may be associated with
postoperative aphasia in the dominant hemisphere. In the
dominant hemisphere, others spare a greater amount of
superior temporal gyrus (STG) with a minimal resection
combined with a 4.5 cm resection of the middle temporal
gyrus (MTG) [115]. An even more conservative approach is
to spare the entire STG and only resect 3.5 cm of the MTG
[116]. Alternatively, the lateral resection can be tailored based
on stimulation mapping of the essential language sites and
avoiding resections within 2 cm of these sites [117].
The most conservative approach to the resection of the
mesial structures can be accomplished by various selective
approaches through a transcortical-transventricular [118] or
a transsylvian approach [119]. The selective approach was
based on a concept from Hughlings Jackson’s description of
an uncal lesion causing psychomotor seizures and the role
of the mesial temporal lobe in epilepsy [58]. Subsequent
experiments provided evidence that these structures play an
important role in mTLE [120, 121]. This generated surgical
interest in attempting to achieve the best results for seizure
outcomes while sparing resection of brain tissue that is
not believed to be involved in the generation of seizures.
In theory, this approach is thought by some authors to
have neuropsychological advantages compared to a more
aggressive neocortical resection [122].
3.1.2. nTLE. The amount of neocortex to be resected in
nTLE should include the epileptogenic zone as determined
by preoperative testing and possibly intra-operative ECOG
which seeks to identify the irritative zone through recording
pre-resection IEDs. In the dominant hemisphere, the extent
of posterior resection is limited by language areas. Complete
removal of a radiographically identified lesion usually results
in cessation of seizures when lesions are well circumscribed
(e.g., benign tumors or cavernous hemangiomas) [123, 124].
However, in lesions with ill-defined borders such as cortical
dysplasia and posttraumatic gliosis, the likelihood of opera-
tive success is lower as microscopic damage surrounding the
visible boundaries of the lesion may be present [125].
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3.2. Extent of Mesial Resection. Since the introduction of
the en bloc ATL and the subsequent advent of selective
procedures, there is much debate regarding the identity of the
critical structures that should be removed to achieve seizure
freedom in a temporal resection.
3.2.1. Hippocampal Resection. The general consensus is that
the hippocampus should be included in resective procedures
for TLE; however, the degree of hippocampal resection is
controversial. Wyler et al.’s randomized trial demonstrated
that patients that underwent a total hippocampectomy
(extending to the superior colliculus) were more likely to
be seizure free at 1-year followup compared to patients that
underwent a partial hippocampectomy (extending to the
lateral edge of the cerebral peduncle) [57]. Undergoing a
partial hippocampectomy is controversial especially if the
epileptogenic zone has been localized to the hippocampus.
In addition, a partial resection of the hippocampus will
result in its deafferentation from the entorhinal cortex and
thus render it ineffective for memory storage and recall.
Therefore, a partial resection is not an effective strategy.
3.2.2. Parahippocampal Resection. The parahippocampal
gyrus (PHG) is generally removed along with the hippocam-
pus. There is evidence from depth electrode studies to suggest
that epileptiform activity originating from the PHG and
amygdala is more likely to manifest clinically than activity
from the hippocampus [126]. Furthermore, a retrospective
study by YaSargil et al. had demonstrated that the volume
of PHG resected had a greater impact on seizure outcome
than the volume of any other mesial temporal lobe structure
[119].
3.2.3. Amygdalar Resection. The amygdala has intricate con-
nections with both limbic and neocortical structures and
a great propensity to generate seizures as demonstrated
following kindling experiments [127]. The combination of
focal epileptic discharges from the periamygdaloid region
and stimulationmapping able to reproduce automatisms and
amnesia in this region indicated the importance of including
the amygdala in TLE resections [128, 129]. Interestingly,
some studies suggest that amygdalar sclerosis may in fact
occur in isolation from the hippocampus [130].
3.3. Risks Associated with Surgery for TLE. Despite the
potential to achieve excellent seizure control, TLE surgery is
associated with several risks specific to the procedure: motor,
visual field, cranial nerve, language, memory, cognitive,
and psychiatric deficits. The cumulative morbidity for TLE
surgery, not considering adverse psychiatric outcomes, is
approximately 11% with permanent deficits in approxi-
mately 3% [24, 131].
3.3.1. Motor Deficits. Contralateral hemiplegia is a well-
described complication of TLE surgery. It is thought to result
due to manipulation of the anterior choroidal artery with
subsequent infarction of the posterior limb of the internal
capsule. This is estimated to occur in 2% of the cases with
the majority of patients improving over the course of several
months to a year [132, 133].
3.3.2. Cranial Nerve Deficit. Cranial nerve morbidity is
mainly associated with the oculomotor (CNIII) and the
trochlear (CNIV) nerves. The oculomotor nerve traverses the
ambient cistern bordering the medial aspect of the temporal
lobe on route to the cavernous sinus. The trochlear nerve
travels lateral to the cerebral peduncles and between the
posterior cerebral and superior cerebellar arteries lateral to
the oculomotor nerve prior to entering the cavernous sinus.
Cranial nerve injury occurs most commonly due to traction,
is estimated at 1.5–3%, and is usually transient [132, 134].
3.3.3. Visual Field Deficits. The most common visual field
deficit following TLE is a superior quadrantanopsia, resulting
from damage to the optic radiations comprising the most
lateral aspect of Meyer’s loops as they course inferomedially.
However, visual deficits can range from small triangular
defects to a complete homonymous hemianopsia. A more
extensive hemianopsia has been attributed to a greater
amount of resection as well as individual variance on
the course of the optic radiations. A randomized trial of
temporal lobe epilepsy surgery found quadtrantic visual
field defects in 55% of the patients [35]. However, in the
vast majority of cases, this is diagnosed on formal visual
field testing and the patient is unaware of this deficit [35].
A selective surgical approach does not appear to offer an
advantage [135]. Damage to the optic radiations in these
cases has been attributed to suction devices and retractors
being driven through the optic radiations en route to the
mesial temporal lobe structures.
3.3.4. Language Deficit. Dominant TLE surgery is associated
with a language risk due to the close proximity of Broca’s
and Wernicke’s area localized to the inferior frontal gyrus
and the posterior STG, respectively. However, the most
common language deficit is a transient anomia [136, 137].
Some surgeons routinely perform a tailored resection by
conducting intra-operative language mapping and/or avoid
resection of the STG, while others argue that this does
not provide a benefit [136]. In a large multicenter study
comparing a tailored resection utilizing intra-operative map-
ping, tailored resection without intra-operative mapping,
a standard approach sparing the STG, and a standard
approach not sparing the STG, a similar decline in visual
confrontational naming as assessed by the Boston Naming
Test (BNT) was observed in all groups with no differences
between groups [138]. Although there is variability between
centers, most do not perform tailored resections according
to language mapping, and they routinely spare the STG
except the first centimeter or so [116]. A multicenter trial
demonstrated that early age of seizure onset was a protective
factor for postoperative anomia, perhaps due to the early
collateralization of language [139].
3.3.5. Memory Deficit. While the Wada test is an important
adjunct that assesses the ability of the contralateral hemi-
sphere in supporting memory function, carefully selected
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patients may still suffer significant memory deficits follow-
ing TLE surgery. The lateral neocortical temporal lobe is
associated with naming and short-term working memory
while the mesial temporal lobe is implicated in long-term
consolidation of memory and retrieval [140]. In individuals
with typical language dominance, visuospatial and verbal
memory is commonly associated with the right and left
hippocampi, respectively [141]. High ipsilateral memory
function and lack of radiographic features of MTS on
preoperative MRI are associated with a greater degree of
postoperative memory decline. Patients with contralateral
hippocampal dysfunction are generally not candidates for
an ipsilateral mesial temporal lobe resection as bilateral
hippocampal lesions can result in a severe anterograde
amnesia [140, 142].
3.3.6. Psychiatric Risks. TLE has been associated with a
high risk (almost 50%) of depression [143]. In particular,
a preoperative history of depression is a strong predictor
of postoperative depression [143]. In addition, suicide rates
are 5 times greater than the general population. While
most patients improve following surgery as a result of
greater seizure control and increased independence, others
are at risk of developing further psychiatric illnesses. In
a cohort of 28 patients undergoing ATL, impairments of
facial recognition of expression of fear, anger, disgust, and
sadness were identified [144]. Although rare, some patients
may develop a psychotic-type illness similar to schizophrenia
[145]. Therefore, there must be a lowthreshold to refer a
patient for psychiatric assessment.
4. Case Examples
4.1. Typical MTS. Ms. A is a 34-year-old, right-hand-
dominant female who presented with her first convulsive
seizure at the age of 27 years although a detailed past
history suggested that she may have been suffering from
brief partial seizures without loss of awareness for many
years prior to that. These seizures were confirmed on EEG.
Initial drug therapy, with 400mg per day of carbamazepine,
maintained her seizure free for 7 years until she presented
again with a generalized tonic-clonic seizure (GTCS) during
sleep. Subsequently her dose was increased to 800mg per
day, but this did not fully prevent the GTCSs. Also, she had
been suffering from simple partial seizures as well as up to 7
CPSs per month. She described auras of nausea and a “funny
feeling” up her spine. She also felt that she tried to remember
something that had not happened. This would then tend
to be followed by a blank stare and lip smacking. From a
neuropsychological point of view, she complained of blunted
emotions and poor memory.
Ms. A was admitted to the EMU where 7 seizures from
the right temporal lobe, all with maximal onset over the
anterior/mid and basolateral structures were detected. One
of the seizures secondarily generalization towards the end of
this event ictal discharges was recorded over the left posterior
temporal structures. MRI demonstrated sclerosis of the right
mesial temporal lobe (Figure 1). Neuropsychological testing
demonstrated deficits in non-verbal memory. Given that all
testing was concordant with a right mTLE, a right selective
amygdalohippocampectomy was recommended. The proce-
dure was carried out without complications. At 6-month
postoperative followup, Ms. A was free of seizures including
auras. She had been maintained on her preoperative medi-
cations. She noted significant improvement of memory and
concentration.
4.2. MRI Normal nTLE. Mr. B is a 28-year-old, right-
hand dominant who was first seen at the age of 22 for
evaluation of a long-standing seizure disorder. He had
been suffering from complex partial seizures from the age
of 10, which were described as periods of disorientation,
twitching, lip smacking, picking at his shirt, and difficulties
with speech lasting 1-2 minutes. He also described auras of
epigastric discomfort and fear. He had not experienced any
GTCSs seizures or secondary generalization of his seizures.
Carbamazepine, valproic acid, and phenytoin had been
attempted without significant benefit. Previous MRI with
supplementary detailed views of the temporal lobes was
normal (Figure 2). Mr. B was subsequently admitted to the
EMU, with scalp EEG monitoring.
Abnormalities, concentrated in the left anterior quadrant
of the head, consisted of continuous dysrhythmia with
spread to the frontal regions in the form of long-lasting 4-
5Hz, monorhythmic trains of activity with abrupt onset and
offset without clinical accompaniment. He demonstrated
interictal slow wave activity localizing to the left mesial tem-
poral as well as left temporal region. Furthermore, distinctive
phase reversals were identified in electrodes approximating
Wernicke’s area and inferior. Ictal activity always began
on the left side starting anteriorly and then proceeding
posteriorly. Main source imaging spikes all localized to the
mesial temporal region. No inter-ictal activity was noted in
the posterior temporal region.
Neuropsychological evaluation demonstrated dimin-
ished verbal functioning with a pattern most consistent
with left-sided neocortical dysfunction rather than mesial
temporal (verbal learning and retention were excellent).
fMRI revealed left hemispheric language dominance. As
a result of these investigations, the benefit of a surgical
resection was unknown. He was discharged on 100mg
per day of topiramate, which also failed to decrease his
seizures. Therefore, to better delineate the site of seizure
onset and for functional mapping, intracranial monitoring
was recommended.
A large square grid was placed at the end of the
distal sylvian fissure and overlying the inferior and supe-
rior parietal lobules. Three subtemporal strip electrodes
(labeled as frontal, middle, and posterior temporal) were also
placed. Subsequent monitoring in the EMU demonstrated
the middle temporal subdural strip electrode to be most
epileptogenic. MRI correlated these leads to the left inferior
temporal and fusiform gyri.
Surgical resection, guided by ECOG and language map-
ping, was performed. The mesial temporal structures were
spared to avoid memory deficits. Pathological examination
revealedmild cortical and subcortical gliosis. Postoperatively,
he experienced a few very brief auras (similar to ones
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Figure 1: Ms. A—FLAIR and T2-weighted MR demonstrating right MTS as can be identified based on the loss of architecture and high
signal of flair images.
R L
Figure 2: Mr. B—normal MR.
experienced in the past) but no progression to CPSs. He
also complained of poor memory and reading ability, but
spoken language was intact. He was maintained on 400mg
per day of topiramate. At 2 years postoperative followup, Mr.
B was seizure free although he did complain of intermittent
sensations of his typical aura. He also complained of mild
word finding difficulties which did not interfere with daily
life. He maintained a full-time job without any difficulties.
4.3. Dual Pathology. Mr. C is a 34-year-old, left-hand-
dominant man who started having seizures at 25 years of
age. His family described his episodes as starting with a few
minutes of increased rate and volume of speech followed
by fatigue, slowed speech, and occasional automatisms.
Postictally, he would fall asleep and rarely remember these
episodes. Seizures occurred approximately twice a week. He
presented to the hospital following his first episode of a
GTCS.
EMU studies at a peripheral hospital had been able to
record eight seizures of similar clinical semiology. Two were
electrographically of left temporal origin while the remaining
six were poorly lateralized, appearing bi-hemispheric and
perhaps even right hemispheric predominancy at onset
followed by rhythmic activity localized to the left temporal
head regions within 3-4 seconds. An ictal SPECT scan
during one of these episodes demonstrated left temporal
activation. MRI at that point had been interpreted as normal.
Conservative medical management with trials of phenytoin,
topiramate, and pregabalin was attempted without success.
For further clarification, he wasmonitored in the EMU at
our institution where bilateral inter-ictal abnormalities from
both the left anterior temporal regions as well as the right
midlateral or midposterior temporal regions were demon-
strated. On certain days, seizures, of a 3 : 1 ratio, favoring
the right hemisphere was observed. He also had multiple
electrographic seizures that were either poorly lateralized
or not lateralized at onset. Subsequent MRI demonstrated
left HS in addition to signal abnormalities in the inferior
right temporal region as well, likely representing cortical
dysplasia (Figure 3). Neuropsychological testing suggested a
full-scale IQ of 119 with only a slight relative weakness in
verbal memory; otherwise, the tests were nonlateralizing. At
this point, he had worsening depression, loss of motivation,
and problems with short-term memory and concentra-
tion, all contributing to him quitting his graduate degree.
To better delineate the epileptogenic focus/foci, anterior
and posterior temporal strip electrodes, subtemporal strip
electrodes, along with hippocampal depth electrodes, were
placed bilaterally for EMU monitoring.
During this stay, many CPSs, all stereotypically involv-
ing the right temporal mesial and neocortical structures
before spreading to involve the left temporal mesial and
neocortical structures, were noted. The exact localization
within the right temporal lobe was not clear given that
the first electrographic changes were subtle and comprising
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Figure 3: Mr. C—T2-weighted and FSTIR sequence MR demonstrating a right inferior temporal lobe lesion in addition to left MTS.
of an attenuation of background activity over the right
hippocampal depth and RMT electrode contacts. Occasional
low-amplitude 20Hz rhythms at right hippocampal depth
electrode 2 prior to subsequent spread were also detected.
Left temporal spiking, occurring more frequently than right
temporal spiking, raised the concern regarding the role of
the left temporal lobe being involved; however, brief ictal
rhythmic discharges appeared solely from the right temporal
lobe structures which correlated well with the patient’s
clinically relevant seizures. Given that the seizures were
primarily right-sided but that he also demonstrated left-
sided HS, a WADA test was performed which showed left-
sided memory dominance. He has been scheduled for a right
TLY.
5. Conclusion
Once a patient has been deemed medically refractory, the
main requirement to determine surgical candidacy is the
ability to accurately localize the epileptogenic zone [146].
There are tools in the armamentarium of the epilepsy team to
help localize the epileptogenic zone and ensure that resection
can be done in a safe manner to minimize any neurologic
deficit. All ancillary testing is not employed simultaneously;
rather they are tailored to the anatomical, electrical, and
clinical features of each patient [147]. The best patients for
surgical resection are those with concordance in localization
of their seizures electrographically, radiographically, and
semiologically.
TLE is the most common epilepsy syndrome that is
responsive to surgical treatment. Although various patholo-
gies can give rise to TLE including cortical dysplasia,
tumours, and vascular malformations, HS remains the most
common entity. Surgical patient selection is made after a
thorough discussion of each case in a multidisciplinary con-
ference including epileptologists, epilepsy surgeons, neuro-
radiologists, neuropsychologists, clinical psychologists, EEG
technologists, and nurses. In the appropriately selected
patients, seizure freedom can be achieved with no or
manageable neurological deficits following surgery.
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